Home › Funds › GSA CAPITAL PARTNERS LLP › ONC
GSA CAPITAL PARTNERS LLP position in ONC
BEONE MEDICINES LTD · Health Care
GSA CAPITAL PARTNERS LLP reported holding 9,151 shares of ONC (BEONE MEDICINES LTD) in its Q3 2026 13F filing — a position valued at US$3.3M, representing 0.20% of its reported portfolio and ranking #42 among its reported holdings. GSA CAPITAL PARTNERS LLP has disclosed ONC holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GSA CAPITAL PARTNERS LLP's ONC position evolved
GSA CAPITAL PARTNERS LLP first disclosed a stake in ONC in Q1 2025 at 3,159 shares (US$860K). The position peaked in Q3 2026 at 9,151 shares, worth US$3.3M. Across 6 filings, GSA CAPITAL PARTNERS LLP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 9,151 shares valued at US$3.3M — an increase of 4,417 shares quarter over quarter.. Notable position changes include a 42% increase in Q2 2026 (shares rose 28% over the following quarter), a 93% increase in Q3 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.16K | $860.00K | New |
| Q2 2025 | 3.31K | $801.00K | Add |
| Q3 2025 | 3.22K | $1.10M | Reduce |
| Q1 2026 | 3.33K | $989.00K | New |
| Q2 2026 | 4.73K | $1.35M | Add |
| Q3 2026 | 9.15K | $3.35M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 30 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.80B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 4.91M sh · $1.80B · Q3 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Two Sigma Investments 656.71K sh · $240.31M · Q3 2026
- Siren, L.L.C. 465.00K sh · $170.16M · Q3 2026
- Candriam S.C.A. 289.24K sh · $106.23M · Q3 2026
- Capital International, Inc./CA/ 290.16K sh · $106.18M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 240.59K sh · $88.04M · Q3 2026
- Capital International Sarl 206.19K sh · $75.45M · Q3 2026
More on GSA CAPITAL PARTNERS LLP
FAQ
How long has GSA CAPITAL PARTNERS LLP held ONC?
GSA CAPITAL PARTNERS LLP has disclosed ONC holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
What is GSA CAPITAL PARTNERS LLP's current position in ONC?
As of Q3 2026, GSA CAPITAL PARTNERS LLP holds 9.15K shares of ONC (BEONE MEDICINES LTD), valued at $3.35M, representing 0.20% of its reported portfolio and ranking #42.
Has GSA CAPITAL PARTNERS LLP been buying or selling ONC?
In the latest 13F filing (Q3 2026), GSA CAPITAL PARTNERS LLP increased its position in ONC. The position peaked in Q3 2026 at 9.15K shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.